Testicular seminoma

A.Prof Frank Gaillard ◉ and Dr Andrew Dixon ◉ et al.

Testicular seminomas are the most common testicular tumours and account for ~45% of all primary testicular tumours. This article concerns itself only with testicular seminomas, however, seminomas can arise outside of the testicle most often within the anterior mediastinum, e.g. anterior mediastinal germ cell tumours.

undescended testis is the major risk factor for testicular germ cell tumours
- 10-40x increased risk
- ~10% of tumours are associated with undescended testis
- increased risk in the contralateral normally descended testis
previous tumour in the contralateral testis
family history of testicular germ cell tumour
testicular microlithiasis: controversial risk factor, although some sources claim an ~8x increased risk ²
other risk factors include infections such as HIV, mumps, orchitis, and history of trauma or organ transplant immunosuppression

See the article on risk factors for testicular germ cell tumour for more detail.

Clinical presentation

The most common presentation is with a painless testicular mass although some 45% will report a degree of testicular discomfort. Bilateral tumours are rare (~2%) and are almost always asynchronous ¹. Diagnosis following trauma is common as it draws the patient’s attention to the lump. Back pain, abdominal discomfort or abdominal mass may be a presenting feature in the 25% of patients who have retroperitoneal nodal metastases ³. Presentation with distant or extranodal metastases is rare (~5%).

Pathology

Seminoma by definition must be pure seminoma on histology and not associated with an elevated serum alpha-fetoprotein (AFP). If either of these criteria is not met then, the tumour must be classified as non-seminomatous and managed accordingly. Uncommonly (15%) b-HCG may be slightly elevated. Pure seminomas are subdivided into three histological subtypes:

classic: 85%, infrequent mitoses; monotonous sheet of large cells with abundant cytoplasm and round hyperchromatic nuclei, prominent nucleoli
anaplastic: 10%, ≥3 mitotic figures per high-power field
spermatocytic: 5%, older male patients above 60 years old, rarely metastasise; well-differentiated with cells resembling secondary spermatids

On gross examination, seminomas are pale grey to yellow nodules that are uniform or slightly lobulated and often bulge from the cut surface. Tumour staging is via a TNM system (see testicular cancer staging).

Radiographic features

Ultrasound

Ultrasound is the first line imaging modality if a patient presents with a testicular abnormality. Features include:

seminomas usually appear as a homogeneous intratesticular mass of low echogenicity compared to normal testicular tissue
the mass is usually oval and well-defined in the absence of local invasion
- usually confined within the tunica albuginea, rarely extending to paratesticular structures
internal blood flow is seen on colour Dopper imaging
cystic regions and calcifications are less common than in non-seminomatous germ cell tumours
larger seminomas can have a heterogeneous appearance

CT

Abdominal and pelvic CT are important in visualising metastases both as a part of primary staging seminoma but also in primary diagnosis when a testicular mass is unknown.

Metastases to the para-aortic lymph nodes at the level of the renal vessels are the typical first site of spread owing to the lymphatic drainage of the testicles relating to embryological testicular descent. The nodal metastases are often bulky, of homogenous density and tend to encase surrounding vessels.

Inguinal or iliac lymph node metastases suggest lymphatic spread via the scrotum and therefore local tumour extension beyond the tunica vaginalis.

Visceral metastases are seen in ~5% of patients at presentation (lung, liver, bone, brain). Staging CT of the chest is only indicated when regional para-aortic lymph node spread is present or if there is an abnormal chest x-ray.

Following therapy, lymph node metastases reduce markedly in size but some inactive abnormal tissue persists which can be difficult to distinguish from residual disease and follow-up monitoring is required.

MRI

Usually appear as multinodular tumours of uniform signal intensity ^3-4:

T2: hypointense to normal testicular tissue
T1+C (Gd): inhomogeneous enhancement

Nuclear medicine

FDG-PET is less sensitive in initial staging than CT. Usually only used following treatment of seminoma to look for metabolic activity within residual lymphadenopathy or extranodal metastases.

Treatment and prognosis

Treatment involves surgical removal of the testicular primary (orchiectomy).

Radiotherapy to regional nodes if there is local disease (stage I) or limited nodal para-aortic metastases (non-bulky stage II) may be necessary (seminomas are radiosensitive, whereas non-seminomatous tumours are not).

Chemotherapy may be necessary if there is bulky para-aortic lymph node involvement of more distant disease. Four cycles of bleomycin, etoposide, and cisplatin (BEP) is currently standard of care.

Prognosis is good for all stages with greater than 90% cure rate. Survivors have an increased lifetime risk of developing other malignancies including testicular cancer in the remaining testicle, mesothelioma and cancer of the lung, colon, bladder, pancreas, and stomach.

Differential diagnosis

The main differential for testicular mass in young adults is non-seminomatous germ cell tumour (NGCT) which usually appear more heterogeneous, often with cysts and calcification. Lymphadenopathy of NGCT may enhance more heterogeneously.

Testicular lymphoma is the main differential diagnosis to consider when para-aortic lymphadenopathy is the presenting finding or in the setting of bilateral testicular lesions.